Health & Medicine

Diseases & Treatments

Switzerland authorizes first Covid-19 drug

Émission

Forum
27 December 2021

Alexandra Calmy

HUG

Médecine, UNIGE

The Swiss drug agency Swissmedic has given the green light to Roche's Ronapreve, a combination of antibodies that can be used for the treatment or prophylaxis of Covid-19.

Related interventions

Sections

Health & Medicine

Diseases & Treatments

Covid-19, a drug with questions

- Oriol Manuel
  
  CHUV | UNIL

27 December 2021

Sections

Health & Medicine

Diseases & Treatments

Update on new vaccines approved in Switzerland

- Blaise Genton
  
  CHUV | UNIL

04 February 2021

Sections

Health & Medicine

Diseases & Treatments

FDA clears synthetic antibodies against Covid

- Jean Villard
  
  HUG | UNIGE

24 November 2020

Sections

Health & Medicine

Diseases & Treatments

Tocilizumab: the new weapon against Covid-19

- Jean Villard
  
  HUG | UNIGE

28 April 2020

Sections

Health & Medicine

Diseases & Treatments

A drug based on faecal matter

- Tatiana Katerina Galperine
  
  CHUV | UNIL

29 January 2025

Sections

Health & Medicine

Diseases & Treatments

The number of Swiss victims of Depakine may be underestimated

- Alice Panchaud
  
  CHUV | UNIL

10 June 2021

Sections

Health & Medicine

Diseases & Treatments

Antiretrovirals against Covid-19

- Alexandra Calmy
  
  HUG | UNIGE

23 March 2020

Sections

Health & Medicine

Diseases & Treatments

Swissmedic authorizes a new booster vaccine against Omicron

- Frédérique Jacquérioz Bausch
  
  HUG

29 August 2022